Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma.

HAEMATOLOGICA(2020)

引用 3|浏览8
暂无评分
关键词
Autoimmunity,Cell Therapy and Immunotherapy,Indolent Non-Hodgkin's Lymphoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要